Lose Weight

Explore research peptides commonly discussed for appetite regulation, fat metabolism, and body-composition support—then compare providers and expected trajectories.

  • 10

    Peptides

  • 9,200+

    Reviews

  • 45

    Research Studies

  • 15

    Provider Partners

Lose Weight visual
  • Reduces Appetite
  • Increases Fat Burning
  • Improves Metabolism
  • Preserves Lean Muscle

Top Peptides for Lose Weight

  • #1 Best Overall

    GLP-3 Retatrutide

    4.8 (1,256)

    Avg. Weight Loss

    24%

    Research Quality
    ★★★★★
    Side Effects
    Mild GI
    Cost
    $$$
    Best For
    Max fat loss
    View Details
  • #2 Best for Most People

    GLP-2 Tirzepatide

    4.7 (2,840)

    Avg. Weight Loss

    21%

    Research Quality
    ★★★★★
    Side Effects
    Mild GI
    Cost
    $$
    Best For
    Balanced results
    View Details
  • #3 Best for Beginners

    Cagrilintide

    4.5 (980)

    Avg. Weight Loss

    Research Quality
    ★★★★☆
    Side Effects
    Mild GI
    Cost
    $$
    Best For
    Appetite research
    View Details
View All 10 Peptides

Expected Results Over Time

lbs
0w12w24w36w48w167 lbs174 lbs174 lbs
GLP-3 RetatrutideGLP-2 TirzepatideCagrilintide

GLP-3 Retatrutide: You could lose ~53 lbs (24%) in 48 weeks.

Top Rated Providers

  • PS

    Peptide Sciences

    Coming soon

    4.9 $199/mo

    Free Shipping

  • CP

    Core Peptides

    Coming soon

    4.8 $179/mo

    Lab Tested

  • LP

    Limitless Life

    Coming soon

    4.7 $165/mo

    Fast Ship

Real Results from Real People

  • Marcus T.

    Lost 42 lbs

    5.0

    Comparing providers side by side made the whole process clearer. Results tracked close to what the chart suggested.

  • Elena R.

    Lost 28 lbs

    4.8

    I liked seeing research quality next to cost. Helped me pick a beginner-friendly option first.

  • Jordan K.

    Lost 51 lbs

    5.0

    The expected results chart was surprisingly useful for setting a realistic 6-month goal.

Research Backed

View all studies
  • Phase 3 SURMOUNT-5 Trial Results

    Dual-agonist outcomes for body weight vs comparator therapy over 72 weeks.

    NEJM, 2024

  • Retatrutide Phase 2 Dose Response

    Triple-agonist weight-loss signals across escalating dose cohorts.

    Lancet, 2023

  • GLP-1 Lean Mass Preservation Review

    Narrative review of lean-mass outcomes alongside fat-mass reduction.

    Obesity Reviews, 2024

Helpful Resources

View All Resources

Stay updated on the latest peptide research

New studies, guides, and calculator tools in your inbox.